Rapid Titration of Heart Failure Therapies by Etiology: An Analysis of STRONG-HF [0.03%]
基于病因快速滴定心力衰竭治疗方案的STRONG-HF分析
Rahul Aggarwal,Deepak L Bhatt,Alexandre Mebazaa et al.
Rahul Aggarwal et al.
Where There's Smoke, There's Fire: It Is Time to Find a Fire Extinguisher for Elevated Filling Pressures in Heart Failure [0.03%]
试析心力衰竭患者过高填压的现象及应对措施
Arvind Bhimaraj,Salil Kumar
Arvind Bhimaraj
Kidney Function Decline in Incident Heart Failure Is a Surrogate Marker for Kidney Failure and Mortality [0.03%]
肾功能不全作为新发心力衰竭患者慢性肾脏病和死亡率的替代标志
Carl P Walther,Katherine R Tuttle,Sankar D Navaneethan
Carl P Walther
Risk Factors and Temporal Trends of Maternal Heart Failure: A Population-Based Study Over 2 Decades [0.03%]
基于人群的队列研究：20年内母亲心力衰竭的风险因素及时间趋势分析
Clara Kihlborg,Jonas Faxén,Maria Sennström et al.
Clara Kihlborg et al.
Background: Maternal heart failure (HF) is increasing in several countries, but trends in Sweden remain unclear. The extent to which changes in maternal risk factors contribute to this trend and the proportion of cases li...
Temporal Changes in Biomarkers, Functional Status, and Quality of Life Prior to Adverse Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction [0.03%]
射血分数轻度降低或保留的心力衰竭患者临床不良结局前生物标志物、功能状态和生活质量的时空变化
Henri Lu,Brian L Claggett,Muthiah Vaduganathan et al.
Henri Lu et al.
Background: Mapping clinical, biomarker, and diuretic dosing trajectories before adverse clinical outcomes in patients with heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) may inform popula...
Disease Penetrance in Genotype-Positive But Clinically Unaffected Relatives From Families With Dilated Cardiomyopathy [0.03%]
家族性扩张型心肌病基因型阳性但临床未受影响的亲属的疾病渗透率
Douglas E Cannie,Athanasios Bakalakos,Petros Syrris et al.
Douglas E Cannie et al.
Background: Serial clinical assessment of genotype-positive relatives from families with dilated cardiomyopathy (DCM) is recommended, but there are limited data to guide screening intervals. ...
Contemporary Antibody-Mediated Rejection in Heart Transplantation: JACC: Heart Failure Position Statement [0.03%]
心脏移植中的当代抗体介导排斥反应：JACC心力衰竭立场文件
Aditya Mehta,Ersilia M DeFilippis,Josef Stehlik et al.
Aditya Mehta et al.
Heart transplantation remains the definitive therapy for patients with advanced heart failure. Acute and chronic rejection affect both short- and long-term outcomes. Antibody-mediated rejection (AMR) remains a leading cause of graft failure...
All That Glitters Is Not Gold: Exploring Metal Exposures as Risk Factors for Incident Heart Failure [0.03%]
闪光的不全是金子：探索金属暴露作为首次发生心力衰竭的风险因素
Sukrit Narula,Andrew Y Chang
Sukrit Narula
Capturing Totality of Treatment Effects: A Model-Free Approach to Analyzing Multiple Event-Time Data From Heart Failure Studies [0.03%]
全面捕捉治疗效应：一种分析心力衰竭研究中多重事件时间数据的非参数方法
Stephanie Armbruster,Zachary R McCaw,Karola Jering et al.
Stephanie Armbruster et al.
Clinical Presentation, Biomarker Trajectories, and Outcomes in Women and Men Hospitalized for Acute Heart Failure [0.03%]
急性心力衰竭住院男性和女性患者的临床特点、生物标志物动态及预后特征
Alice Ravera,Hailun Qin,Jozine M Ter Maaten et al.
Alice Ravera et al.
Background: Previous studies have shown important but sometimes heterogeneous differences between women and men with heart failure (HF). Objectives: ...